| abstract |
The present invention relates to methods and compositions for treating bladder disease. In particular, the method provides for the treatment of interstitial cystitis and related diseases. The method further affects a variety of symptoms associated with interstitial cystitis, including reduced histamine release, regulation of substance P expression, regulation of neuronal growth factor expression, regulation of various cytokine levels, and maintenance of the integrity of the urine / blood barrier. Includes treatments that affect. |